Neuroone Medical Technologies (NMTC) Treasury Shares (2018 - 2026)

Neuroone Medical Technologies has disclosed Treasury Shares across 9 years of filings, most recently posting $14788.0 for Q1 2026.

• Quarterly Treasury Shares fell 5.92% year-over-year to $14788.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14788.0 (down 5.92% YoY) and the FY2025 annual result came in at $812696.0, down 28.06% from the prior year.
• Treasury Shares climbed to $14788.0 in Q1 2026, from $680.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.1 million in Q3 2024 and bottomed at $4.08 in Q2 2025.
• The 5-year median for Treasury Shares is $15253.5 (2025), against an average of $208547.2.
• Year-over-year, Treasury Shares jumped 3540.46% in 2022 and slumped 99.99% in 2025.
• Neuroone Medical Technologies' Treasury Shares stood at $414430.0 in 2022, then plunged by 97.3% to $11176.0 in 2023, then tumbled by 81.43% to $2075.0 in 2024, then plunged by 67.23% to $680.0 in 2025, then soared by 2074.71% to $14788.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $14788.0, $680.0, and $812696.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.